STING1 and breast carcinoma: On the other hand, cGAS-STING pathway promotes tumor progression in melanoma (70), breast cancer (71, 72), lung cancer (73) and skin cancer (74) by promoting tumor immune escape and metastasis and maintaining chronic inflammation.